Age groups (years) | 15–49 | 15–19 | 20–24 | 25–29 | 30–34 | 35–39 | 40–44 | 45–49 | Data source |
---|---|---|---|---|---|---|---|---|---|
Total number of pregnant women expected | 995, 533 | 231, 982 | 202, 093 | 173, 223 | 125, 437 | 108, 513 | 80, 638 | 73, 647 | |
HIV prevalence, % | 5.6 | 2.0 | 3.4 | 7.6 | 7.3 | 10.0 | 7.1 | 6.4 | Cameroon [18] |
Access to Antenatal Care), % | 36.5 | Cameroon [19] | |||||||
Prenatal HIV testing, % | 29.3 | Cameroon [19] | |||||||
Receipt of maternal HIV test result, % | 92.4 | Cameroon [19] | |||||||
Mortality during pregnancy, % | 4 | Cameroon [19] | |||||||
Live birth among HIV uninfected women, % | 95 | ||||||||
Live birth among HIV infected women, % | 94.6 | 72.7 | 68.9 | 63.3 | 58.4 | 52.0 | 51.9 | ||
ARV prophylactic coverage for HIV infected pregnant women, % | 20.3 | Cameroon [19] | |||||||
CD4 cell count quantification for HIV infected women, % | 6.9 | Cameroon [19] | |||||||
Pregnant women ART eligible in ANC, % | 60 | Cameroon [19] | |||||||
ART coverage for eligible women in ANC, % | 25 | Cameroon [19] | |||||||
HIV MTCT rate at 6-week in the absence of MTCT, % | 22 | ||||||||
Treatment Effectiveness Expected | |||||||||
-Short course ARV (% reduction) | 86.7 | ||||||||
-Long course ARV/ ART (% reduction) | 93.7 | ||||||||
Rate of breastfeeding exposure among HIV exposed children known at birth (%) | 46 | Cameroon, Pediacama 1, CIRCB field studiesb | |||||||
Rate of breastfeeding exposure among children not known to be HIV exposed at birth, (%) | 97 | Cameron [18] | |||||||
Intra-partum incidence of HIV infection (per 100 woman-year of follow-up), % | 2 | 2 | 1.6 | 1.3 | 1 | 0.6 | 0.6 | ||
Incident HIV infections among lactating women, % | 2.0 | ||||||||
Proportion of children still exposed to breastfeeding (age in months), % | Cameroon [18] | ||||||||
[0,2[ | 97.5 | ||||||||
[2,4[ | 98.9 | ||||||||
[4,6[ | 96.0 | ||||||||
[6,9[ | 95.9 | ||||||||
[9,12[ | 90.5 | ||||||||
[12,18[ | 70.2 | ||||||||
[18, 24] | 29.5 | ||||||||
Rate of exclusive breastfeeding among non HIV exposed children (age in months), % | Cameroon [18] | ||||||||
[0,2[ | 31.2 | ||||||||
[2,4[ | 23.0 | ||||||||
[4,6[ | 10.6 | ||||||||
[6,9[ | 1.9 | ||||||||
[9,12[ | 0.8 | ||||||||
[12,18[ | 0.7 | ||||||||
[18, 24] | 0.0 | ||||||||
Rate of exclusive breastfeeding among HIV exposed children (age in months), % | Cameroon, | ||||||||
Pediacama 1, CIRCB field studiesb | |||||||||
[0,2[ | 86.6 | ||||||||
[2,6[ | 75.9 | ||||||||
[6,12[ | 50.4 | ||||||||
[12, 18] | 0.0 | ||||||||
Proportion of HIV exposed children who received postnatal ART, % | 9.2 | Cameroon [19] | |||||||
Rate of mother’s retention in ART treatment after delivery | Sub-saharan Africa [42] | ||||||||
[0,6[ | 79.1 | ||||||||
[6,12[ | 75.0 | ||||||||
[12, 24] | 61.6 |